نتائج البحث - Keane Maccon

  • يعرض 1 - 17 نتائج من 17
تنقيح النتائج
  1. 1
    Review of Triple Negative Breast Cancer and the Impact of Inducible Nitric Oxide Synthase on Tumor Biology and Patient Outcomes

    Review of Triple Negative Breast Cancer and the Impact of Inducible Nitric Oxide Synthase on Tumor Biology and Patient Outcomes حسب Walsh, Elaine M., Keane, Maccon M., Wink, David A., Callagy, Grace, Glynn, Sharon A.

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    The Death Domain Kinase RIP Is Essential for TRAIL (Apo2L)-Induced Activation of IκB Kinase and c-Jun N-Terminal Kinase

    The Death Domain Kinase RIP Is Essential for TRAIL (Apo2L)-Induced Activation of IκB Kinase and c-Jun N-Terminal Kinase حسب Lin, Yong, Devin, Anne, Cook, Amy, Keane, Maccon M., Kelliher, Michelle, Lipkowitz, Stanley, Liu, Zheng-gang

    منشور في 2000
    احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre

    The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre حسب McVeigh, Terri Patricia, Hughes, Lauren M., Miller, Nicola, Sheehan, Margaret, Keane, Maccon, Sweeney, Karl J., Kerin, Michael J.

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy

    Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy حسب Walsh, Elaine M., Shalaby, Aliaa, O’Loughlin, Mark, Keane, Nessa, Webber, Mark J, Kerin, Michael J., Keane, Maccon M., Glynn, Sharon A., Callagy, Grace M.

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways

    Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways حسب Garrido, Pablo, Shalaby, Aliaa, Walsh, Elaine M., Keane, Nessa, Webber, Mark, Keane, Maccon M., Sullivan, Francis J., Kerin, Michael J., Callagy, Grace, Ryan, Aideen E., Glynn, Sharon A.

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score©

    A Novel Surrogate Nomogram Capable of Predicting OncotypeDX Recurrence Score© حسب Davey, Matthew G., Jalali, Amirhossein, Ryan, Éanna J., McLaughlin, Ray P., Sweeney, Karl J., Barry, Michael K., Malone, Carmel M., Keane, Maccon M., Lowery, Aoife J., Miller, Nicola, Kerin, Michael J.

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial

    Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial حسب Janet E. Brown, Emma Rathbone, Samantha Hinsley, Walter M. Gregory, Fatma Gossiel, Helen Marshall, Roger Burkinshaw, Helen Shulver, Hasina Thandar, Gianfilippo Bertelli, Keane Maccon, Angela Bowman, Andrew M. Hanby, Richard H. Bell, David Cameron, Robert E. Coleman

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer

    Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer حسب McGuire, Andrew, Casey, Maire-Caitlin, Waldron, Ronan M., Heneghan, Helen, Kalinina, Olga, Holian, Emma, McDermott, Ailbhe, Lowery, Aoife J., Newell, John, Dwyer, Róisín M., Miller, Nicola, Keane, Maccon, Brown, James A.L., Kerin, Michael J.

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study

    Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast canc... حسب Davey, Matthew G., Kerin, Eoin, O'Flaherty, C., Maher, Elizabeth, Richard, Vinitha, McAnena, Peter, McLaughlin, Ray P., Sweeney, Karl J., Barry, Michael K., Malone, Carmel M., Wyns, William, Soliman, Osama, Miller, Nicola, Keane, Maccon M., Lowery, Aoife J., Kerin, Michael J.

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial

    Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phas... حسب Sonnenblick, Amir, Agbor-Tarh, Dominique, Bradbury, Ian, Di Cosimo, Serena, Azim, Hatem A., Fumagalli, Debora, Sarp, Severine, Wolff, Antonio C., Andersson, Michael, Kroep, Judith, Cufer, Tanja, Simon, Sergio D., Salman, Pamela, Toi, Masakazu, Harris, Lyndsay, Gralow, Julie, Keane, Maccon, Moreno-Aspitia, Alvaro, Piccart-Gebhart, Martine, de Azambuja, Evandro

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland

    Understanding and Attitudes toward Cancer Clinical Trials among Patients with a Cancer Diagnosis: National Study through Cancer Trials Ireland حسب Kearns, Cathriona, Feighery, Ronan, Mc Caffrey, John, Higgins, Michaela, Smith, Martina, Murphy, Verena, O’Reilly, Seamus, Horgan, Anne M., Walshe, Janice, McDermott, Ray, Morris, Patrick G., Keane, Maccon, Martin, Michael, Murphy, Conleth, Duffy, Karen, Mihai, Alina, Armstrong, John, O’Donnell, Dearbhaile M., Gallagher, William M., Kelly, Ciara M., Kelly, Catherine M.

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer “PantHER”

    Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer “PantHER” حسب Keegan, Niamh M., Furney, Simon J., Walshe, Janice M., Gullo, Giuseppe, Kennedy, M. John, Smith, Diarmuid, McCaffrey, John, Kelly, Catherine M., Egan, Keith, Kerr, Jennifer, Given, Mark, O’Donovan, Peter, Hernando, Andres, Teiserskiene, Ausra, Parker, Imelda, Kay, Elaine, Farrelly, Angela, Carr, Aoife, Calzaferri, Giulio, McDermott, Ray, Keane, Maccon M., Grogan, Liam, Breathnach, Oscar, Morris, Patrick G., Toomey, Sinead, Hennessy, Bryan T.

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08–10 trial

    Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis o... حسب Gullo, Giuseppe, J. Eustace, Alex, Canonici, Alexandra, M. Collins, Denis, Kennedy, Michael J., Grogan, Liam, Breathhnach, Oscar, McCaffrey, John, Keane, Maccon, Martin, Michael J., Gupta, Rajnish, Leonard, Gregory, O’Connor, Miriam, Calvert, Paula M., Donnellan, Paul, Walshe, Janice, McDermott, Enda, Scott, Kathleen, Hernando, Andres, Parker, Imelda, W. Murray, David, C. O’Farrell, Alice, Maratha, Ashwini, Dicker, Patrick, Rafferty, Mairin, Murphy, Verena, O’Donovan, Norma, M. Gallagher, William, Ky, Bonnie, Tryfonopoulos, Dimitrios, Moulton, Brian, T. Byrne, Annette, Crown, John

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial

    Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAI... حسب Sparano, Joseph A., Gray, Robert J., Makower, Della F., Albain, Kathy S., Saphner, Thomas J., Badve, Sunil S, Wagner, Lynne I., Kaklamani, Virginia G., Keane, Maccon M., Gomez, Henry L., Reddy, Pavan S., Goggins, Timothy F., Mayer, Ingrid A., Toppmeyer, Deborah L., Brufsky, Adam M., Goetz, Matthew P., Berenberg, Jeffrey L., Mahalcioiu, Catalin, Desbiens, Christine, Hayes, Daniel F., Dees, Elizabeth C., Geyer, Charles E., Olson, John A., Wood, William C, Lively, Tracy, Paik, Soonmyung, Ellis, Matthew J., Abrams, Jeffrey, Sledge, George W.

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial

    Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial حسب Albain, Kathy S, Gray, Robert J, Makower, Della F, Faghih, Amir, Hayes, Daniel F, Geyer, Charles E, Dees, Elizabeth C, Goetz, Matthew P, Olson, John A, Lively, Tracy, Badve, Sunil S, Saphner, Thomas J, Wagner, Lynne I, Whelan, Timothy J, Ellis, Matthew J, Wood, William C, Keane, Maccon M, Gomez, Henry L, Reddy, Pavan S, Goggins, Timothy F, Mayer, Ingrid A, Brufsky, Adam M, Toppmeyer, Deborah L, Kaklamani, Virginia G, Berenberg, Jeffrey L, Abrams, Jeffrey, Sledge, George W, Sparano, Joseph A

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

    Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer حسب Sparano, Joseph A., Gray, Robert J., Makower, Della F., Pritchard, Kathleen I., Albain, Kathy S., Hayes, Daniel F., Geyer, Charles E., Dees, Elizabeth C., Goetz, Matthew P., Olson, John A., Lively, Tracy, Badve, Sunil S., Saphner, Thomas J., Wagner, Lynne I., Whelan, Timothy J., Ellis, Matthew J., Paik, Soonmyung, Wood, William C., Ravdin, Peter M., Keane, Maccon M., Moreno, Henry L. Gomez, Reddy, Pavan S., Goggins, Timothy F., Mayer, Ingrid A., Brufsky, Adam M., Toppmeyer, Deborah L., Kaklamani, Virginia G., Berenberg, Jeffrey L., Abrams, Jeffrey, Sledge, George W.

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

    Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer حسب Sparano, Joseph A., Gray, Robert J., Ravdin, Peter M., Makower, Della F., Pritchard, Kathleen I., Albain, Kathy S., Hayes, Daniel F., Geyer, Charles E., Dees, Elizabeth C., Goetz, Matthew P., Olson, John A., Lively, Tracy, Badve, Sunil S., Saphner, Thomas J., Wagner, Lynne I., Whelan, Timothy J., Ellis, Matthew J., Chir, B., Paik, Soonmyung, Wood, William C., Keane, Maccon M., Gomez Moreno, Henry L., Reddy, Pavan S., Goggins, Timothy F., Mayer, Ingrid A., Brufsky, Adam M., Kaklamani, V.G., Toppmeyer, Deborah L., Kaklamani, Virginia G., Berenberg, Jeffrey L., Abrams, Jeffrey, Sledge, George W.

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: